Theravance Biopharma (TBPH) feels very nice.
What’s up with Theravance Biopharma?
Theravance Biopharma (TBPH) opened at $30.35, which means the stock is down 4.99% from yesterday’s closing price of 30.69. Today, the company has a high of $30.91 and a low of $29.09. The company has a market cap of $1.837 billion with a 52-week high of $31.54 and a 52-week low of $15.18.
What about the future forTheravance Biopharma
The high forecast for Theravance Biopharma is 40.00 while the low is 20.00. Stock forecasts are based on human experience: Human traders based on their experience in terms of stock price patterns, volume changes, and market news/rumors regarding a particular stock. Theravance Biopharma has a weak forecast. A weak forecast is due to the company posting consistent losses in their earning reports. The future outlook does not seem too bright as this could potentially cause the company to file for bankruptcy.. Based on this information TBPH seems to be a risky buy.
About Theravance Biopharma
Theravance Biopharma, Inc. (“Theravance Biopharma”) is a diversified biopharmaceutical company primarily focused on the discovery, development and commercialization of organ-selective medicines. Our purpose is to create transformational medicines to improve the lives of patients suffering from serious illnesses. Our research is focused in the areas of inflammation and immunology.